Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Increased efficacy of micro-opioid agonist-induced antinociception by metabotropic glutamate receptor antagonists in C57BL/6 mice: comparison with (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959).

Fischer BD, Miller LL, Henry FE, Picker MJ, Dykstra LA.

Psychopharmacology (Berl). 2008 Jun;198(2):271-8. doi: 10.1007/s00213-008-1130-y. Epub 2008 Apr 8.

PMID:
18392754
4.
6.
7.

Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects.

Fischer BD, Ward SJ, Henry FE, Dykstra LA.

Neuropharmacology. 2010 Feb;58(2):544-50. doi: 10.1016/j.neuropharm.2009.08.005. Epub 2009 Aug 21.

8.

Opioid antinociception, tolerance and dependence: interactions with the N-methyl-D-aspartate system in mice.

Dykstra LA, Fischer BD, Balter RE, Henry FE, Schmidt KT, Miller LL.

Behav Pharmacol. 2011 Sep;22(5-6):540-7. doi: 10.1097/FBP.0b013e328348ed08.

10.

Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors.

Lutfy K, Eitan S, Bryant CD, Yang YC, Saliminejad N, Walwyn W, Kieffer BL, Takeshima H, Carroll FI, Maidment NT, Evans CJ.

J Neurosci. 2003 Nov 12;23(32):10331-7.

11.
12.
15.

Antinociceptive effects and synergistic interaction with morphine of intrathecal metabotropic glutamate receptor 2/3 antagonist in the formalin test of rats.

Yoon MH, Choi Jl, Bae HB, Kim SJ, Chung ST, Jeong SW, Chung SS, Yoo KY, Jeong CY.

Neurosci Lett. 2006 Feb 20;394(3):222-6. Epub 2005 Nov 15.

PMID:
16293369
16.

Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.

Khroyan TV, Polgar WE, Jiang F, Zaveri NT, Toll L.

J Pharmacol Exp Ther. 2009 Dec;331(3):946-53. doi: 10.1124/jpet.109.156711. Epub 2009 Aug 27.

17.

Morphine in combination with metabotropic glutamate receptor antagonists on schedule-controlled responding and thermal nociception.

Fischer BD, Zimmerman EI, Picker MJ, Dykstra LA.

J Pharmacol Exp Ther. 2008 Feb;324(2):732-9. Epub 2007 Nov 2.

19.

Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.

Ide S, Minami M, Satoh M, Uhl GR, Sora I, Ikeda K.

Neuropsychopharmacology. 2004 Sep;29(9):1656-63.

20.

Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.

Kögel B, Christoph T, Strassburger W, Friderichs E.

Eur J Pain. 2005 Oct;9(5):599-611.

PMID:
16139189

Supplemental Content

Support Center